N
IBIO icon

Nuveen’s iBio IBIO Stock Holding History

Nuveen’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,796
Closed -$360K – 3362
2022
Q1 		$360K Sell
1,796
-17
-0.9% -$3.56K ﹤0.01% 3086
2021
Q4 		$580K Sell
1,813
-143
-7% -$54.5K ﹤0.01% 3037
2021
Q3 		$1.2M Buy
1,956
+19
+1% +$11.8K ﹤0.01% 2920
2021
Q2 		$1.46M Buy
1,937
+716
+59% +$522K ﹤0.01% 2850
2021
Q1 		$940K Buy
1,221
+135
+12% +$118K ﹤0.01% 2904
2020
Q4 		$570K Buy
1,086
+514
+90% +$419K ﹤0.01% 3012
2020
Q3 		$581K Buy
572
+11
+2% +$15.9K ﹤0.01% 2901
2020
Q2 		$623K Buy
+561
New +$367K ﹤0.01% 2817

Other funds holding IBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return